The APAC Coagulation/Hemostasis Analyzer Market Size was valued at USD 784.91 million in 2022 and is estimated to reach USD 1296.02 million by 2027, growing at a CAGR of 10.55%, from 2022 to 2027.
The growth of the senior population, an increase in the prevalence of chronic illnesses such as blood disorders and cardiovascular diseases, the development of point-of-care (POC) coagulation testing, and the rise in laboratory automation are all driving the Asia Pacific coagulant analyzer market. Hemostasis-coagulation analyzers are becoming more widely used because of the rising frequency of bleeding and other lifestyle-related disorders.
Government funding for the development of coagulation hemostasis analyzers to treat various diseases drives the growth of the Hemostasis-Coagulation Analysis Market. To improve patients' quality of life suffering from thrombotic and bleeding disorders, the leading players are concentrating on developing advanced clinical laboratory analyzers and point-of-care diagnostic analyzers. The demand for advanced analyzers has risen in response to the increased request for correct findings in less time, boosting the Hemostasis-Coagulation Analysis Market even more.
In addition, the growing population base suffering from the standard of living and persistent blood problems are predicted to drive up demand for coagulation analyzers.
Furthermore, increased awareness of these disorders is expected to increase diagnostic speed and preventative care supervision, resulting in a significant increase in testing volume. The country under investigation and analysis is currently experiencing a shift, with large sums of government funding being spent to acquire and install such medical technology in their community healthcare institutions. In the future, a growing older population, an increase in the prevalence of chronic illness, and rapid growth in foreign investments are expected.
The market is being held back by the high cost of fully automated coagulation analyzers and the slow adoption of improved hemostasis tools in this nation. As a result, the market's significant players collaborate to conduct various research and development efforts to release advanced hemostasis-coagulation analyzers to treat multiple bleeding diseases. However, market growth is likely to be limited over the forecast period due to lack of information, government agency strict rules and regulations for device clearance, and slow adoption of new devices.
This research report on the Asia Pacific Coagulation/Hemostasis Analyzer Market has been segmented and sub-segmented into the following categories
By Test:
By Product:
By End User:
By Technology:
By Country:
Geographically, the Asia Pacific is expected to grow at a fastest rate throughout the forecast period due to the growth and expansion of the healthcare industry in this area and an increase in the number of general surgeries. As a result, adopting APTT tests for detecting coagulation inhibitors is growing, and key companies are focusing more on developing advanced hemostasis-coagulation analyzers, propelling this industry ahead. In addition, because of the increased usage of technology and the aim of healthcare industries to reach emerging economies such as India, the Asia-Pacific area is likely to increase in the future.
Furthermore, the growing population of people suffering from lifestyle-related diseases and chronic blood problems is expected to demand coagulation analyzers. Additionally, raising awareness about these illnesses will likely enhance diagnosis rates and preventative care management, resulting in a significant rise in testing volume.
KEY MARKET PLAYERS
Top Companies leading the Asia Pacific Coagulation/Hemostasis Analyzer Market Profiled in the Report are, Alere Inc. (U.S.), , Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), International Technidyne Corporation (U.S.), Siemens AG (Germany), Sysmex Corporation (Japan).,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Test
5.1.1 ACT
5.1.2 aPTT
5.1.3 D Dimer testing
5.1.4 Platelet Function Test
5.1.5 Prothrombin Time Testing
5.1.6 Anti-Factor Xa Test
5.1.7 Heparin and Protamine Dose Response Test for ACT
5.1.8 Fibrinogen Testing
5.1.9 Other Coagulation Tests
5.1.10 Y-o-Y Growth Analysis, By Test
5.1.11 Market Attractiveness Analysis, By Test
5.1.12 Market Share Analysis, By Test
5.2 Product
5.2.1 PoC Testing Analyzers
5.2.2 Clinical Laboratory Analyzers
5.2.2.1 Systems
5.2.2.1.1 Manual Systems
5.2.2.1.2 Automated Systems
5.2.2.1.3 Semiautomated Systems
5.2.2.2 Consumables
5.2.2.2.1 Reagents
5.2.2.2.2 Standards, Calibrations and Controls
5.2.3 Y-o-Y Growth Analysis, By Product
5.2.4 Market Attractiveness Analysis, By Product
5.2.5 Market Share Analysis, By Product
5.3 End Users
5.3.1 Clinical Laboratories
5.3.2 Point-Of-Care Testing
5.3.3 Other End Users
5.3.4 Y-o-Y Growth Analysis, By End Users
5.3.5 Market Attractiveness Analysis, By End Users
5.3.6 Market Share Analysis, By End Users
5.4 Technology
5.4.1 Electrochemical Technology
5.4.2 Optical Technology
5.4.3 Mechanical Technology
5.4.4 Other Technologies
5.4.5 Y-o-Y Growth Analysis, By Technology
5.4.6 Market Attractiveness Analysis, By Technology
5.4.7 Market Share Analysis, By Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Test
6.1.3.2 By Product
6.1.3.3 By End Users
6.1.3.4 By Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Test
6.1.4.2 By Product
6.1.4.3 By End Users
6.1.4.4 By Technology
6.1.5 Market Share Analysis
6.1.5.1 By Test
6.1.5.2 By Product
6.1.5.3 By End Users
6.1.5.4 By Technology
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Siemens AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Roche Diagnostics
8.4 Alere Inc.
8.5 Sysmex Corporation
8.6 Helena Laboratories
8.7 Instrumentation Laboratory
8.8 International Technidyne Corporation
8.9 Nihon Kohden Corporation
8.10 Diagnostica Stago
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
